9 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Task Force on Clinical ... Society of America #HFrEF ... #HeartFailure #Management ... #treatment #algorithm
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... immunotherapy; FEV1: forced ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... assessment test; FEV1, forced ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... corticosteroid; FEV1: forced ... #Management #Pulmonary
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... #differential #algorithm ... #management #cardiology ... #foamed #heartfailure ... #pharmacology
Perhaps quite too often, the knee-jerk reaction to an elevated Troponin is to call our friends
This becomes a flawed ... #diagnosis #algorithm ... #management #clinical ... #criticalcare #foamed ... #treatment
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
which all carry treatment ... breakdown of glycogen stores ... #differential #algorithm ... #management #treatment ... #criticalcare #foamed
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... event, follow ACC algorithm ... Change in clinical ... one post op Cardiology ... medical and surgical management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management